Continuation of “Innovate for Smiles 2018” and Revision of Management Targets
First written in FY2016-Q2. 3 of 5 entries say "Restated". Latest entry: FY2017-Q2.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- FY2017-Q2DroppedAnnual report
「The Group established “Innovate for Smiles 2018,” a medium- to long-term management plan launched in fiscal 2014 and ending in fiscal 2018, and worked as a group to build a distinctive and firmly established position in the mail-order market and develop new businesses suited to its corporate vision, “Woman Smile Company.” However, following a downward revision to its results forecast in fiscal 2017 due to changes in the business environment and other factors, the Group withdrew its sales and profit plan for fiscal 2018, the final year of the plan.」
The sales and profit plan for fiscal 2018, the final year of “Innovate for Smiles 2018,” was explicitly withdrawn. While the basic policies for each business have not changed, the performance targets for the former final year have been withdrawn. - FY2017-Q1RestatedAnnual report
「The Group is working as one toward achieving its targets in the fourth year of “Innovate for Smiles 2018,” its medium- to long-term management plan ending in fiscal 2018.」
“Innovate for Smiles 2018” has entered its fourth year, and efforts to execute the plan and achieve its targets for fiscal 2018, the final year, are continuing. No new targets or changes to initiatives are described. - FY2016RestatedAnnual report
「Specifically, the Company has established new management targets for fiscal 2018 of consolidated net sales of ¥165.0 billion, operating income of ¥5.0 billion and return on equity (ROE) of 7%.」
“Innovate for Smiles 2018,” ending in fiscal 2018, and its targets of consolidated net sales of ¥165.0 billion, operating income of ¥5.0 billion and ROE of 7% remain in place. - FY2016-Q3RestatedAnnual report
「Specifically, the Company has established new management targets for the fiscal year ending December 2018 of consolidated net sales of ¥165.0 billion, operating income of ¥5.0 billion and return on equity (ROE) of 7%.」
The revised targets for net sales, operating income and ROE for the fiscal year ending December 2018, as well as the continuation of the plan, have been reiterated. There are no further changes to the target figures or plan. - FY2016-Q2First statedAnnual report
「The Group is working as one toward achieving its targets in the third year of “Innovate for Smiles 2018,” its medium- to long-term management plan ending in fiscal 2018.」
In light of changes in the external environment, shortfalls against the sales and profit plans, and changes in the Group structure resulting from capital and business alliances and the conversion of companies into subsidiaries, the Group has reviewed part of its strategy and its management targets while retaining its basic policies. It has established new targets of consolidated net sales of ¥165.0 billion, operating income of ¥5.0 billion and ROE of 7% for the fiscal year ending December 2018.